Epidemiology and national trends in prevalence and surgical management of metastatic spinal disease

Samantha R. Horn, Ekamjeet S. Dhillon, Gregory W. Poorman, Jared C. Tishelman, Frank A. Segreto, Cole A. Bortz, John Y. Moon, Omar Behery, Nicholas Shepard, Bassel G. Diebo, Shaleen Vira, Peter G. Passias

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Surgical treatment for spinal metastasis has benefited from improvements in surgical techniques. However, the trends in treatment and outcomes for spinal metastasis surgery have not been well-established in a pediatric population. Patients <20 years old with metastatic spinal tumors undergoing spinal surgery were identified in the KID database. Trends for spinal metastases treatment and patient outcomes were analyzed using weight-adjusted ANOVAs. 333 patients were identified in the KID database. The top five primary diagnoses were metastatic brain/spinal cord tumor (19.8%), metastatic nervous system tumor (15.9%), metastatic bone cancer (13.2%), spinal cord tumor (4.2%), and tumor of ventricles (3.0%). There was an increased incidence of spinal metastasis diagnoses from 2003 to 2012 (88.5–117.9 per 100,000; p < 0.001) and an increased trend in the incidence of surgical treatment for spinal metastasis from 2003 to 2012 (p = 0.014). The average age was 10.19 ± 6.33 years old and 38.4% were female. The average length of stay was 17.34 ± 24.36 days. Average CCI increased over time (2003: 7.87 ± 1.40, 2012: 8.44 ± 1.39; p = 0.006). The most common surgeries were excision of spinal cord/meninges lesions (69.1%) and decompression of spinal canal (38.1%). Length of hospital stay and in-hospital mortality did not change over time (17.34–18.04 days, p = 0.337; 1.6%–2.9%, p = 0.801). 10.5% of patients underwent a posterior fusion and 22.2% had at least one complication (nervous system, respiratory, dysphagia, infection). The overall complication rate remained stable over time (23.4%–21.8%, p = 0.952). Surgical treatment for spinal metastasis in the last decade has increased, though the complication rates, in-hospital mortality, and length of stay have remained stable.

Original languageEnglish (US)
Pages (from-to)183-187
Number of pages5
JournalJournal of Clinical Neuroscience
Volume53
DOIs
StatePublished - Jul 2018
Externally publishedYes

Fingerprint

Spinal Diseases
Epidemiology
Neoplasm Metastasis
Length of Stay
Spinal Cord Neoplasms
Hospital Mortality
Databases
Nervous System Neoplasms
Meninges
Bone Neoplasms
Spinal Canal
Incidence
Deglutition Disorders
Decompression
Respiratory Tract Infections
Nervous System
Neoplasms
Spinal Cord
Analysis of Variance
Therapeutics

Keywords

  • Cancer
  • Metastasis
  • Pediatric spine
  • Spine
  • Spine metastasis
  • Spine surgery

ASJC Scopus subject areas

  • Surgery
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Horn, S. R., Dhillon, E. S., Poorman, G. W., Tishelman, J. C., Segreto, F. A., Bortz, C. A., ... Passias, P. G. (2018). Epidemiology and national trends in prevalence and surgical management of metastatic spinal disease. Journal of Clinical Neuroscience, 53, 183-187. https://doi.org/10.1016/j.jocn.2018.04.022

Epidemiology and national trends in prevalence and surgical management of metastatic spinal disease. / Horn, Samantha R.; Dhillon, Ekamjeet S.; Poorman, Gregory W.; Tishelman, Jared C.; Segreto, Frank A.; Bortz, Cole A.; Moon, John Y.; Behery, Omar; Shepard, Nicholas; Diebo, Bassel G.; Vira, Shaleen; Passias, Peter G.

In: Journal of Clinical Neuroscience, Vol. 53, 07.2018, p. 183-187.

Research output: Contribution to journalArticle

Horn, SR, Dhillon, ES, Poorman, GW, Tishelman, JC, Segreto, FA, Bortz, CA, Moon, JY, Behery, O, Shepard, N, Diebo, BG, Vira, S & Passias, PG 2018, 'Epidemiology and national trends in prevalence and surgical management of metastatic spinal disease', Journal of Clinical Neuroscience, vol. 53, pp. 183-187. https://doi.org/10.1016/j.jocn.2018.04.022
Horn, Samantha R. ; Dhillon, Ekamjeet S. ; Poorman, Gregory W. ; Tishelman, Jared C. ; Segreto, Frank A. ; Bortz, Cole A. ; Moon, John Y. ; Behery, Omar ; Shepard, Nicholas ; Diebo, Bassel G. ; Vira, Shaleen ; Passias, Peter G. / Epidemiology and national trends in prevalence and surgical management of metastatic spinal disease. In: Journal of Clinical Neuroscience. 2018 ; Vol. 53. pp. 183-187.
@article{b33759242db04705bf020fc3b9b2d39d,
title = "Epidemiology and national trends in prevalence and surgical management of metastatic spinal disease",
abstract = "Surgical treatment for spinal metastasis has benefited from improvements in surgical techniques. However, the trends in treatment and outcomes for spinal metastasis surgery have not been well-established in a pediatric population. Patients <20 years old with metastatic spinal tumors undergoing spinal surgery were identified in the KID database. Trends for spinal metastases treatment and patient outcomes were analyzed using weight-adjusted ANOVAs. 333 patients were identified in the KID database. The top five primary diagnoses were metastatic brain/spinal cord tumor (19.8{\%}), metastatic nervous system tumor (15.9{\%}), metastatic bone cancer (13.2{\%}), spinal cord tumor (4.2{\%}), and tumor of ventricles (3.0{\%}). There was an increased incidence of spinal metastasis diagnoses from 2003 to 2012 (88.5–117.9 per 100,000; p < 0.001) and an increased trend in the incidence of surgical treatment for spinal metastasis from 2003 to 2012 (p = 0.014). The average age was 10.19 ± 6.33 years old and 38.4{\%} were female. The average length of stay was 17.34 ± 24.36 days. Average CCI increased over time (2003: 7.87 ± 1.40, 2012: 8.44 ± 1.39; p = 0.006). The most common surgeries were excision of spinal cord/meninges lesions (69.1{\%}) and decompression of spinal canal (38.1{\%}). Length of hospital stay and in-hospital mortality did not change over time (17.34–18.04 days, p = 0.337; 1.6{\%}–2.9{\%}, p = 0.801). 10.5{\%} of patients underwent a posterior fusion and 22.2{\%} had at least one complication (nervous system, respiratory, dysphagia, infection). The overall complication rate remained stable over time (23.4{\%}–21.8{\%}, p = 0.952). Surgical treatment for spinal metastasis in the last decade has increased, though the complication rates, in-hospital mortality, and length of stay have remained stable.",
keywords = "Cancer, Metastasis, Pediatric spine, Spine, Spine metastasis, Spine surgery",
author = "Horn, {Samantha R.} and Dhillon, {Ekamjeet S.} and Poorman, {Gregory W.} and Tishelman, {Jared C.} and Segreto, {Frank A.} and Bortz, {Cole A.} and Moon, {John Y.} and Omar Behery and Nicholas Shepard and Diebo, {Bassel G.} and Shaleen Vira and Passias, {Peter G.}",
year = "2018",
month = "7",
doi = "10.1016/j.jocn.2018.04.022",
language = "English (US)",
volume = "53",
pages = "183--187",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Epidemiology and national trends in prevalence and surgical management of metastatic spinal disease

AU - Horn, Samantha R.

AU - Dhillon, Ekamjeet S.

AU - Poorman, Gregory W.

AU - Tishelman, Jared C.

AU - Segreto, Frank A.

AU - Bortz, Cole A.

AU - Moon, John Y.

AU - Behery, Omar

AU - Shepard, Nicholas

AU - Diebo, Bassel G.

AU - Vira, Shaleen

AU - Passias, Peter G.

PY - 2018/7

Y1 - 2018/7

N2 - Surgical treatment for spinal metastasis has benefited from improvements in surgical techniques. However, the trends in treatment and outcomes for spinal metastasis surgery have not been well-established in a pediatric population. Patients <20 years old with metastatic spinal tumors undergoing spinal surgery were identified in the KID database. Trends for spinal metastases treatment and patient outcomes were analyzed using weight-adjusted ANOVAs. 333 patients were identified in the KID database. The top five primary diagnoses were metastatic brain/spinal cord tumor (19.8%), metastatic nervous system tumor (15.9%), metastatic bone cancer (13.2%), spinal cord tumor (4.2%), and tumor of ventricles (3.0%). There was an increased incidence of spinal metastasis diagnoses from 2003 to 2012 (88.5–117.9 per 100,000; p < 0.001) and an increased trend in the incidence of surgical treatment for spinal metastasis from 2003 to 2012 (p = 0.014). The average age was 10.19 ± 6.33 years old and 38.4% were female. The average length of stay was 17.34 ± 24.36 days. Average CCI increased over time (2003: 7.87 ± 1.40, 2012: 8.44 ± 1.39; p = 0.006). The most common surgeries were excision of spinal cord/meninges lesions (69.1%) and decompression of spinal canal (38.1%). Length of hospital stay and in-hospital mortality did not change over time (17.34–18.04 days, p = 0.337; 1.6%–2.9%, p = 0.801). 10.5% of patients underwent a posterior fusion and 22.2% had at least one complication (nervous system, respiratory, dysphagia, infection). The overall complication rate remained stable over time (23.4%–21.8%, p = 0.952). Surgical treatment for spinal metastasis in the last decade has increased, though the complication rates, in-hospital mortality, and length of stay have remained stable.

AB - Surgical treatment for spinal metastasis has benefited from improvements in surgical techniques. However, the trends in treatment and outcomes for spinal metastasis surgery have not been well-established in a pediatric population. Patients <20 years old with metastatic spinal tumors undergoing spinal surgery were identified in the KID database. Trends for spinal metastases treatment and patient outcomes were analyzed using weight-adjusted ANOVAs. 333 patients were identified in the KID database. The top five primary diagnoses were metastatic brain/spinal cord tumor (19.8%), metastatic nervous system tumor (15.9%), metastatic bone cancer (13.2%), spinal cord tumor (4.2%), and tumor of ventricles (3.0%). There was an increased incidence of spinal metastasis diagnoses from 2003 to 2012 (88.5–117.9 per 100,000; p < 0.001) and an increased trend in the incidence of surgical treatment for spinal metastasis from 2003 to 2012 (p = 0.014). The average age was 10.19 ± 6.33 years old and 38.4% were female. The average length of stay was 17.34 ± 24.36 days. Average CCI increased over time (2003: 7.87 ± 1.40, 2012: 8.44 ± 1.39; p = 0.006). The most common surgeries were excision of spinal cord/meninges lesions (69.1%) and decompression of spinal canal (38.1%). Length of hospital stay and in-hospital mortality did not change over time (17.34–18.04 days, p = 0.337; 1.6%–2.9%, p = 0.801). 10.5% of patients underwent a posterior fusion and 22.2% had at least one complication (nervous system, respiratory, dysphagia, infection). The overall complication rate remained stable over time (23.4%–21.8%, p = 0.952). Surgical treatment for spinal metastasis in the last decade has increased, though the complication rates, in-hospital mortality, and length of stay have remained stable.

KW - Cancer

KW - Metastasis

KW - Pediatric spine

KW - Spine

KW - Spine metastasis

KW - Spine surgery

UR - http://www.scopus.com/inward/record.url?scp=85045829899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045829899&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2018.04.022

DO - 10.1016/j.jocn.2018.04.022

M3 - Article

C2 - 29681425

AN - SCOPUS:85045829899

VL - 53

SP - 183

EP - 187

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -